Immune checkpoint inhibitors in women with gynecologic cancers: Practical considerations.
Sign Up to like & getrecommendations! Published in 2020 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2020.06.499
Abstract: Immune checkpoint inhibitors are an exciting new class of cancer therapeutics. Recently, a PD-1 inhibitor has been approved by the Food and Drug Administration for several indications that are relevant to patients with gynecologic malignancies.… read more here.
Keywords: immune checkpoint; gynecologic cancers; checkpoint inhibitors; women gynecologic ... See more keywords